DexCom Inc. DXCM recently introduced a new direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users. With the new feature, G7 is likely to be the first CGM device that can link ...

Dexcom announced that its G7 diabetes sensor can now link directly to a user’s Apple Watch, allowing them to track their glucose readings in real-time even if their iPhone isn’t nearby. According to ...

Dexcom's Apple Watch app will be ready to go when the device launches in April, the company told the Wall Street Journal. The app, which will not need to seek pre-market approval from the FDA thanks ...

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240605396939/en/ Diabetes management goes hands-free as ...

When the Apple Watch launches in April, one of the first apps that will be available for the device benefits diabetics because it reports glucose levels on a graph. This app -- which was designed by ...

Dexcom Inc. DXCM, a leading glucose monitor manufacturer, has enabled direct Apple Inc.’s AAPL Watch connectivity for its G7 model in the United States. What Happened: The new feature allows G7 users ...

When the Apple Watch launched last year, Dexcom announced that it would have an Apple Watch app ready for its G4 continuous glucose monitor system, and it did. While users could see their CGM data on ...

Dexcom's glucose monitor via the Apple Watch--Courtesy of Dexcom Diabetics could already access data from their Dexcom G5 Mobile Continuous Glucose Monitor via the Health App on their iPhone. Now they ...

Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Wednesday after market hours. Here’s what to look for. DexCom beat analysts’ revenue expectations by 1.8% last quarter, ...

Look here for a clue. There's no foolproof way to know the future for DexCom (Nasdaq: DXCM) or any other company. However, certain clues may help you see potential stumbles before they happen -- and ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose ...